ISPE was present at the recent Brazil Affiliate Conference, held 24–26 October 2016 in São Paulo.
The conference was attended by ISPE CEO and President John Bournas, who spoke on the worldwide status of the biopharmaceutical market and provided an overview of organizational developments. This visit—the first by an ISPE CEO in over 15 years—reaffirmed ISPE’s commitment to sharing knowledge on a global basis with all of our Affiliates. In addition, Dr. Theodora Kourti, ISPE’s Senior Vice President of Global Regulatory Affairs, discussed ongoing regulatory initiatives that the organization is developing to benefit its international Members.
Also in attendance were representatives from Anvisa, the Brazilian National Health Surveillance Agency, and Sindusfarma, the industry syndicate of pharmaceutical products in the state of São Paulo.
Meeting highlights included the official passing of the gavel from outgoing President Alfonso Izarra to current President Marcelo Decanio, inauguration of a new Board, and recognition of the Affiliate’s companies of the year: Nordika Pharmaceutical Engineering and Libbs Farmacêutica.
Before traveling to the 2019 ISPE Annual Meeting & Expo in Las Vegas, the ISPE Japan Affiliate held its annual phar-maceutical plant tour over five days (21–25 October), visiting two plants in Los Angeles, one in Boston, and one in In-dianapolis.
The 2019 ISPE Max Seales Yonker Member of the Year Award was presented to Charlie Wakeham, a data integrity and compliance specialist based in Sydney, Australia, who has played an instrumental role in the development of GAMP®.